IBIO INC (IBIO)       0.728  -0.01 (-1.61%)

0.728  -0.01 (-1.61%)

US4510336096 - Common Stock - After market: 0.71 -0.02 (-2.47%)

IBIO INC0.728

NYSEARCA:IBIO (1/30/2023, 7:04:00 PM)-0.01 (-1.61%)

After market: 0.71 -0.02 (-2.47%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-14 2022-11-14/amc Earnings (Next) 02-13 2023-02-13
Ins Owners 3.11% Inst Owners 274.77%
Market Cap 7.67M Shares 10.53M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 80
IPO 08-18 2008-08-18

Stock Screener Links

Screen Image

American Stock Exchange Stock Screener

Find more stocks on American Stock Exchange

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

IBIO Daily chart

Company Profile

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. The company is headquartered in New York City, New York and currently employs 105 full-time employees. The company went IPO on 2008-08-18. The firm is focusing its technologies on the research and development of novel products at its Drug Discovery Center in California. The firm through its FastPharming Manufacturing System and GlycaneeringSM Technologies develop its portfolio of proprietary biologic drug candidates. The firm operates through two segments: Biopharmaceuticals, and Bioprocessing. Its Biopharmaceuticals segment is engaged in large molecule discovery, development, and licensing activities. Its Bioprocessing segment is engaged in contract development and manufacturing services for recombinant proteins. Its pipeline includes IBIO-100, IBIO-101, IBIO-202, and IBIO-400. Its subsidiary, iBio CDMO LLC, provides FastPharming Contract Development and Manufacturing Services along with GlycaneeringSM Development Services.

Company Info

IBIO INC

600 Madison Avenue, Suite 1601

New York City NEW YORK 77807

P: 13023550650.0

CEO: Thomas F. Isett

Employees: 105

Website: https://www.ibioinc.com/

IBIO News

News Image2 months ago - iBio, Inc.iBio Announces Closing of $3.5 Million Underwritten Public Offering

BRYAN, Texas, Dec. 09, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody...

News Image2 months ago - InvestorPlace7 Penny Stocks to Sell Before They Plunge in 2023

These penny stocks to sell have been incredibly volatile this year and should be discarded from your portfolios heading into 2023.

News Image2 months ago - InvestorPlace25 Penny Stocks to Sell Before They Die

Wondering which small-cap companies you should offload before 2023? Here are the top picks for penny stocks to sell while you still can.

News Image2 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time for another dive into the biggest pre-market stock movers as we check out the latest news traders need to know about on Wednesday!

News Image2 months ago - iBio, Inc.iBio Announces Pricing of $3.5 Million Underwritten Public Offering

BRYAN, Texas, Dec. 06, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody...

News Image2 months ago - iBio, Inc.iBio Announces Proposed Underwritten Public Offering

BRYAN, Texas, Dec. 06, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody...

IBIO Twits

Here you can normally see the latest stock twits on IBIO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example